IL101953A - Medicinal preparations containing 1-) 5-oxohexyl (-3-methyl-N-7 prophylactic for the regeneration of nerve defects after circulatory disturbance - Google Patents

Medicinal preparations containing 1-) 5-oxohexyl (-3-methyl-N-7 prophylactic for the regeneration of nerve defects after circulatory disturbance

Info

Publication number
IL101953A
IL101953A IL10195392A IL10195392A IL101953A IL 101953 A IL101953 A IL 101953A IL 10195392 A IL10195392 A IL 10195392A IL 10195392 A IL10195392 A IL 10195392A IL 101953 A IL101953 A IL 101953A
Authority
IL
Israel
Prior art keywords
interruption
regeneration
propylxanthine
methyl
oxohexyl
Prior art date
Application number
IL10195392A
Other languages
English (en)
Hebrew (he)
Other versions
IL101953A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL101953A0 publication Critical patent/IL101953A0/xx
Publication of IL101953A publication Critical patent/IL101953A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
IL10195392A 1991-05-23 1992-05-21 Medicinal preparations containing 1-) 5-oxohexyl (-3-methyl-N-7 prophylactic for the regeneration of nerve defects after circulatory disturbance IL101953A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4116799 1991-05-23

Publications (2)

Publication Number Publication Date
IL101953A0 IL101953A0 (en) 1992-12-30
IL101953A true IL101953A (en) 1995-07-31

Family

ID=6432229

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10195392A IL101953A (en) 1991-05-23 1992-05-21 Medicinal preparations containing 1-) 5-oxohexyl (-3-methyl-N-7 prophylactic for the regeneration of nerve defects after circulatory disturbance

Country Status (16)

Country Link
US (1) US5475002A (zh)
EP (1) EP0514789B1 (zh)
JP (1) JP3193767B2 (zh)
KR (1) KR100219011B1 (zh)
AT (1) ATE142498T1 (zh)
AU (1) AU651205B2 (zh)
CA (1) CA2069202C (zh)
DE (1) DE59207086D1 (zh)
DK (1) DK0514789T3 (zh)
ES (1) ES2093138T3 (zh)
GR (1) GR3021039T3 (zh)
HU (1) HU207798B (zh)
IE (1) IE75890B1 (zh)
IL (1) IL101953A (zh)
TW (1) TW207497B (zh)
ZA (1) ZA923747B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109796C (en) * 1991-05-24 2004-04-27 James A. Bianco Modulation of cellular response to external stimuli
US5981536A (en) * 1996-07-31 1999-11-09 Hoechst Aktiengesellschaft Use of xanthine derivatives for the modulation of apoptosis
US5856330A (en) * 1996-07-31 1999-01-05 Hoechst Aktiengesellschaft Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin
WO2000071128A1 (en) * 1999-04-06 2000-11-30 Trustees Of Dartmouth College Compositions and method for decreasing neuropathic pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤

Also Published As

Publication number Publication date
IE75890B1 (en) 1997-09-24
KR100219011B1 (ko) 1999-09-01
IL101953A0 (en) 1992-12-30
EP0514789B1 (de) 1996-09-11
DE59207086D1 (de) 1996-10-17
JPH05139976A (ja) 1993-06-08
JP3193767B2 (ja) 2001-07-30
IE921658A1 (en) 1992-12-02
GR3021039T3 (en) 1996-12-31
DK0514789T3 (zh) 1997-02-17
AU651205B2 (en) 1994-07-14
AU1706392A (en) 1992-11-26
CA2069202C (en) 2003-12-09
EP0514789A1 (de) 1992-11-25
HUT61469A (en) 1993-01-28
HU9201695D0 (en) 1992-08-28
HU207798B (en) 1993-06-28
CA2069202A1 (en) 1992-11-24
TW207497B (zh) 1993-06-11
US5475002A (en) 1995-12-12
ZA923747B (en) 1992-12-30
ATE142498T1 (de) 1996-09-15
ES2093138T3 (es) 1996-12-16

Similar Documents

Publication Publication Date Title
US5747507A (en) Cardio-protective agent
PT99690B (pt) Metodo para o tratamento de doencas utilizando derivados de 2'-o-alquil-adenosina e para a preparacao de composicoes que os contem e de um hidrato de 6-ciclo- -hexil-2'-ometil-adenosina
JP3408546B2 (ja) 抗喘息剤
US5475002A (en) Use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery
CH683966A5 (it) Composti della classe dei ftalidrazidici come sostanze attive in agenti anti-ipossici e di difesa.
WO1994005290A1 (en) Platelet aggregation inhibitor
JPS63501497A (ja) 選択的冠血管拡張剤
HU224958B1 (en) Use of teophyllin derivatives for the preparation of pharmaceutical compositions for the prevention and treatment of shock
US4868197A (en) Reducing reperfusion injury with 1,3-dihydro-4-methyl-5-(4-methylthio)benzoyl)-2H-imidazol-2-thione
RU2663836C1 (ru) L-Энантиомер 2-этил-6-метил-3-гидроксипиридиния гидроксибутандиоата, обладающий церебропротекторной активностью
JP3193800B2 (ja) キサンチン誘導体を含有する筋損傷の予防および治療のための製剤
US8158630B2 (en) Application of 2,5 -dihydroxymethyl-3,6-dimethyl pyrazine and its derivates in pharmacy
RU2313341C1 (ru) Средство, обладающее местно-анестезирующим действием
JPH0741424A (ja) 抗炎症剤
JP3247763B2 (ja) キサンチン誘導体からなる血液循環の中断による神経損傷の治療用医薬
EP0115331B1 (en) Medicament for cerebral apoplexy
JPH05246850A (ja) 脳循環の自己調節を安定化するためのキサンチン誘導体の使用
EP0310259A2 (en) Eperisone as a hypotensive agent
JP4582561B2 (ja) 移植による血管病変の発生抑制剤
FR2465716A1 (fr) 1-(alkyle ramifie)-3-(2-haloethyl)-3-nitroso-urees utilisables comme agents antitumoraux
JPH04342526A (ja) 四肢の末梢循環改善剤及び血管攣縮抑制剤
JPH0848631A (ja) 血管透過性亢進抑制剤
US20040048776A1 (en) Medicament for preventive and therapeutic treatment of fibrosis
CS208668B2 (en) Method of making the derivatives of the 20-methyl-13,14-didehydro-pgi2
EP1161244A2 (en) Use of 1,2,4-triazolo[1,5-a]pyrimidine derivatives for treating migraine

Legal Events

Date Code Title Description
KB Patent renewed
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired